Telum Therapeutics
Investments
| Biotech
Invivo Ventures leads an investment round of 4.1 million Euros in the biotech Telum Therapeutics
Invivo Ventures leads an investment round of 4.1 million Euros in the biotech Telum Therapeutics. The operation was advised by Intelectium Funding Accelerator, an advisory firm that worked with the entrepreneurs, Roberto Diez and Rubén Diez, from the design phase of the company’s business strategy to the closing of the transaction. Clave Capital and Cdti-Innvierte have also participated in the operation.